Healthcare Sector Review: Pharmacyclics, Alexion Revenue Reports

Pharmacyclics, Inc. (NASDAQ:PCYC): Reports Q2 revenue $77.9M vs. consensus $2.64M.

The shares closed at $19.80, up $1.81, or 10.05%, on the day. Its market capitalization is $1.36 billion.

Alexion Pharmaceuticals (NASDAQ:ALXN): Sees strong revenue growth quarter to quarter after Q1. Expects R&D to return to target levels of 17%-18% of sales in 2013. Comments made on the Q4 earnings conference call.

The shares closed at $80.41, up $3.72, or 4.85%, on the day. Its market capitalization is $14.89 billion.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.